Columnist Kristin Neva shares family memories of when her husband, Todd, had just been diagnosed when he took their son on ...

As ALS progresses, annual healthcare costs for U.S. patients increase from an average of $31,000 to over $120,000, a Biogen ...

Neurosense is finalizing the protocol of a Phase 3 study of PrimeC for ALS, and plans to submit the protocol for FDA approval ...

Columnist Kristin Neva must take on more caregiver duties as her husband's ALS progresses, which means she must shift her ...

The Centers for Medicare and Medicaid Services is directing all Medicare Advantage plans to cover Qalsody for treating ...

HEALEY ALS, a platform trial testing multiple potential treatments for amyotrophic lateral sclerosis, is amending its master ...

Getting a feeding tube before substantial weight loss may change the disease course and lengthen life with ALS, a study reports.

Worrying about symptom progression a year after her diagnosis, columnist Dagmar Munn decided to develop her own resilience ...

Dazucorilant failed to slow disease progression in ALS patients in the DAZALS Phase 2 clinical trial, but may have extended ...

One of the things I cherished most about my late husband, Jeff, was his love of the holidays. From the year we began dating ...

The experimental therapy Bravyl significantly reduced the spread of toxic TDP-43 protein clumps in a cell model of ALS.

The delay in diagnosing ALS means treatment and supportive care is received later, which can have a significant impact on ...